Titre:
  • Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study
Auteur:Janssens, Ann; Berneman, Zwi Nisan; Offner, Fritz; Snauwaert, Sylvia; Mineur, Philippe; Vanstraelen, Gaetan; Meers, Stef; Spoormans, Isabelle; Bron, Dominique; Vande Broek, Isabelle; Van Bogaert, Charlotte; De Beleyr, Birgit; Smet, Ann; Nielsen, Lasse; Wapenaar, Robert; André, Marc
Informations sur la publication:Clinical Hematology International, 4, 4, page (133-143)
Statut de publication:Publié, 2022-12
Sujet CREF:Hématologie
Mots-clés:Belgium
Chronic lymphocytic leukemia
Effectiveness
Ibrutinib
Real-world evidence
Safety
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2590-0048
info:doi/10.1007/s44228-022-00020-8
info:scp/85150287583